Episode description
Episode description
Apple and Microsoft have each fallen more than 10% from recent highs, losing a combined $500b in market cap in the process. How should you trade the moves lower, and what do they mean for the broader market? Plus, all eyes on Eli Lilly ahead of its earnings report. What you should expect from the drug maker, and how new trials out of Novo Nordisk could change the game.